APO

APOLLO (APO) Closes €3 Billion Capital Solution for Bayer With KKR

Apollo-managed funds and KKR have invested equity into a new entity holding Bayer's long-acting reversible contraceptives business, with Bayer keeping majority control.

REDFILED Newsdesk

REDFILED Newsdesk

— 2 min read
Share
Apollo and KKR invested in a new entity holding Bayer's long-acting reversible contraceptives business.
Source: Wikimedia

Apollo Global Management (APO) said its managed funds and affiliates have closed a €3 billion capital solution for Bayer, completing a deal first announced on July 10. KKR (KKR) joined as what Apollo calls a significant minority participant in the investment.

Read more